What is Andexxa, and what is it used for?
Andexxa (andexanet alfa) is used to reverse the anticoagulant effect of factor Xa inhibitors. It is intended for patients who have life-threatening or uncontrolled bleeding while taking a factor Xa inhibitor (such as apixaban or rivaroxaban) [1].
Which blood thinners does Andexxa reverse?
Andexxa is designed to reverse factor Xa inhibitors. It is commonly discussed in connection with reversal of apixaban and rivaroxaban [1].
What bleeding situations qualify for Andexxa?
Andexxa is indicated for life-threatening or uncontrolled bleeding in patients treated with a factor Xa inhibitor [1].
How is Andexxa given?
Andexxa is given as an intravenous infusion/administration regimen (a treatment course delivered through the IV) [1].
How quickly does Andexxa work?
Andexxa is used to reverse anticoagulation during emergency bleeding care, and its effect is measured by changes in anti–factor Xa activity in clinical evaluation. Exact “time to effect” can vary by patient and anticoagulant taken, and specific timing details are provided in prescribing information and protocols [1].
What does anti–factor Xa reversal mean for patients?
The goal is to reduce the anticoagulant effect so bleeding can be controlled and clotting can resume. Anti–factor Xa activity is one measure used to assess reversal of drug effect [1].
Are there risks or side effects patients ask about?
The prescribing information includes warnings and side effects associated with Andexxa, which clinicians consider when deciding whether the benefits outweigh risks in an emergency bleeding scenario [1].
Does Andexxa replace platelets or clotting factors?
Andexxa works by reversing the anticoagulant effect of factor Xa inhibitors rather than by directly acting as a platelet product. Its intended mechanism is tied to reversal of factor Xa inhibitor activity [1].
What happens after reversal—do patients restart anticoagulation?
After bleeding is controlled, clinicians typically reassess whether and when to restart anticoagulation based on the patient’s clotting risk and bleeding risk. The decision is individualized and guided by medical judgment and available guidance [1].
Where can I find the official Andexxa FAQ?
For detailed, clinician-oriented answers (indications, dosing approach, administration, and safety information), the most reliable source is the official prescribing information and related materials for Andexxa [1].
---
Sources
[1] https://www.ema.europa.eu/en/medicines/human/EPAR/andexxa